Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
American Journal of Nephrology|May 7, 2026
Effects of Sacubitril/Valsartan vs Irbesartan on Urine Tubular Biomarkers in CKD: Findings from the UK HARP-III TrialMichelle A Goonasekera, Greco B Malijan, Rebecca J Sardell, et al.
The Lancet. Diabetes & Endocrinology|October 13, 2025
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysisWilliam G Herrington, Zhaojing J Che, Rebecca Sardell, et al.
Eclinicalmedicine|July 21, 2025
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trialJunwen Zhou, Claire Williams, Natalie Staplin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2024
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trialParminder K Judge, Katherine R Tuttle, Natalie Staplin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY TrialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
Eclinicalmedicine|August 12, 2025
Estimated glomerular filtration rate, albuminuria, and risk of infection: a collaborative meta-analysis of individual participant dataJunichi Ishigami, Aditya Surapaneni, Kunihiro Matsushita, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2024
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
The New England Journal of Medicine|August 28, 2018
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus, Louise Bowman, Marion Mafham, et al.
The New England Journal of Medicine|August 28, 2018
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus, Louise Bowman, Marion Mafham, et al.
Kidney International|June 20, 2024
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protectionHiddo J L Heerspink, Devin Eddington, Juhi Chaudhari, et al.
Pageof 13